In Silico Selection and In Vitro Evaluation of New Molecules That Inhibit the Adhesion of Streptococcus mutants through Antigen I/II
- PMID: 33396525
- PMCID: PMC7795114
- DOI: 10.3390/ijms22010377
In Silico Selection and In Vitro Evaluation of New Molecules That Inhibit the Adhesion of Streptococcus mutants through Antigen I/II
Abstract
Streptococcus mutans is the main early colonizing cariogenic bacteria because it recognizes salivary pellicle receptors. The Antigen I/II (Ag I/II) of S. mutans is among the most important adhesins in this process, and is involved in the adhesion to the tooth surface and the bacterial co-aggregation in the early stage of biofilm formation. However, this protein has not been used as a target in a virtual strategy search for inhibitors. Based on the predicted binding affinities, drug-like properties and toxicity, molecules were selected and evaluated for their ability to reduce S. mutans adhesion. A virtual screening of 883,551 molecules was conducted; cytotoxicity analysis on fibroblast cells, S. mutans adhesion studies, scanning electron microscopy analysis for bacterial integrity and molecular dynamics simulation were also performed. We found three molecules ZINC19835187 (ZI-187), ZINC19924939 (ZI-939) and ZINC19924906 (ZI-906) without cytotoxic activity, which inhibited about 90% the adhesion of S. mutans to polystyrene microplates. Molecular dynamic simulation by 300 nanoseconds showed stability of the interaction between ZI-187 and Ag I/II (PDB: 3IPK). This work provides new molecules that targets Ag I/II and have the capacity to inhibit in vitro the S. mutans adhesion on polystyrene microplates.
Keywords: Streptococcus mutans; adhesion proteins; antigen I/II; dental caries; molecular dynamics; structure-based virtual screening.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components.J Dent Res. 1994 Sep;73(9):1493-502. doi: 10.1177/00220345940730090301. J Dent Res. 1994. PMID: 7523469
-
Involvement of antigen I/II surface proteins in Streptococcus mutans and Streptococcus intermedius biofilm formation.Oral Microbiol Immunol. 2005 Dec;20(6):366-71. doi: 10.1111/j.1399-302X.2005.00244.x. Oral Microbiol Immunol. 2005. PMID: 16238597
-
Insertional inactivation of pac and rmlB genes reduces the release of tumor necrosis factor alpha, interleukin-6, and interleukin-8 induced by Streptococcus mutans in monocytic, dental pulp, and periodontal ligament cells.Infect Immun. 2003 Sep;71(9):5169-77. doi: 10.1128/IAI.71.9.5169-5177.2003. Infect Immun. 2003. PMID: 12933861 Free PMC article.
-
Sulfated vizantin inhibits biofilm maturation by Streptococcus mutans.Microbiol Immunol. 2020 Jul;64(7):493-501. doi: 10.1111/1348-0421.12797. Epub 2020 Jun 8. Microbiol Immunol. 2020. PMID: 32320095
-
Molecule Targeting Glucosyltransferase Inhibits Streptococcus mutans Biofilm Formation and Virulence.Antimicrob Agents Chemother. 2015 Oct 19;60(1):126-35. doi: 10.1128/AAC.00919-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26482298 Free PMC article.
Cited by
-
Novel antimicrobial agents targeting the Streptococcus mutans biofilms discovery through computer technology.Front Cell Infect Microbiol. 2022 Dec 1;12:1065235. doi: 10.3389/fcimb.2022.1065235. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36530419 Free PMC article. Review.
-
Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment.Microorganisms. 2023 Jun 19;11(6):1614. doi: 10.3390/microorganisms11061614. Microorganisms. 2023. PMID: 37375116 Free PMC article. Review.
-
The Application of Small Molecules to the Control of Typical Species Associated With Oral Infectious Diseases.Front Cell Infect Microbiol. 2022 Feb 21;12:816386. doi: 10.3389/fcimb.2022.816386. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35265531 Free PMC article. Review.
-
Antibacterial and Antibiofilm Potential of Chlorophyllin Against Streptococcus mutans In Vitro and In Silico.Antibiotics (Basel). 2024 Sep 20;13(9):899. doi: 10.3390/antibiotics13090899. Antibiotics (Basel). 2024. PMID: 39335072 Free PMC article.
-
Advances and challenges in drug design against dental caries: Application of in silico approaches.J Pharm Anal. 2025 Jun;15(6):101161. doi: 10.1016/j.jpha.2024.101161. Epub 2024 Dec 9. J Pharm Anal. 2025. PMID: 40678483 Free PMC article. Review.
References
-
- Kyu H.H., Abate D., Abate K.H., Abay S.M., Abbafati C., Abbasi N., Abbastabar H., Abd-Allah F., Abdela J., Abdelalim A., et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 doi: 10.1016/S0140-6736(18)32335-3. - DOI - PMC - PubMed
-
- Vos T., Allen C., Arora M., Barber R.M., Brown A., Carter A., Casey D.C., Charlson F.J., Chen A.Z., Coggeshall M., et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 doi: 10.1016/S0140-6736(16)31678-6. - DOI - PMC - PubMed
-
- Lu M., Xuan S., Wang Z. Oral microbiota: A new view of body health. Food Sci. Hum. Wellness. 2019;8:8–15. doi: 10.1016/j.fshw.2018.12.001. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources